Jump to main content
Jump to site search

Issue 16, 2014
Previous Article Next Article

Iron oxide nanoparticles stabilized with dendritic polyglycerols as selective MRI contrast agents

Author affiliations

Abstract

Monodisperse small iron oxide nanoparticles functionalized with dendritic polyglycerol (dPG) or dendritic polyglycerol sulfate (dPGS) are prepared. They are highly stable in aqueous solutions as well as physiological media. In particular, oleic acid capped iron oxide particles (core diameter = 11 ± 1 nm) were modified by a ligand exchange process in a one pot synthesis with dPG and dPGS bearing phosphonate as anchor groups. Dynamic light scattering measurements performed in water and different biological media demonstrate that the hydrodynamic diameter of the particles is only slightly increased by the ligand exchange process resulting in a final diameter of less than 30 nm and that the particles are stable in these media. It is also revealed by magnetic resonance studies that their magnetic relaxivity is reduced by the surface modification but it is still sufficient for high contrast magnetic resonance imaging (MRI). Additionally, incubation of dPGS functionalized iron oxide nanoparticles with human umbilical vein endothelial cells showed a 50% survival at 85 nM (concentration of nanoparticles). Surface plasmon resonance (SPR) studies demonstrate that the dPGS functionalized iron oxide nanoparticles inhibit L-selectin ligand binding whereas the particles containing only dPG do not show this effect. Experiments in a flow chamber with human myelogenous leukemia cells confirmed L-selectin inhibition of the dPGS functionalized iron oxide nanoparticles and with that the L-selectin mediated leukocyte adhesion. These results indicate that dPGS functionalized iron oxide nanoparticles are a promising contrast agent for inflamed tissue probed by MRI.

Graphical abstract: Iron oxide nanoparticles stabilized with dendritic polyglycerols as selective MRI contrast agents

Back to tab navigation

Supplementary files

Publication details

The article was received on 08 Sep 2013, accepted on 12 Jun 2014 and first published on 13 Jun 2014


Article type: Paper
DOI: 10.1039/C3NR04793H
Citation: Nanoscale, 2014,6, 9646-9654
  • Open access: Creative Commons BY license
  •   Request permissions

    Iron oxide nanoparticles stabilized with dendritic polyglycerols as selective MRI contrast agents

    D. Nordmeyer, P. Stumpf, D. Gröger, A. Hofmann, S. Enders, S. B. Riese, J. Dernedde, M. Taupitz, U. Rauch, R. Haag, E. Rühl and C. Graf, Nanoscale, 2014, 6, 9646
    DOI: 10.1039/C3NR04793H

    This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. Material from this article can be used in other publications provided that the correct acknowledgement is given with the reproduced material.

    Reproduced material should be attributed as follows:

    • For reproduction of material from NJC:
      [Original citation] - Published by The Royal Society of Chemistry (RSC) on behalf of the Centre National de la Recherche Scientifique (CNRS) and the RSC.
    • For reproduction of material from PCCP:
      [Original citation] - Published by the PCCP Owner Societies.
    • For reproduction of material from PPS:
      [Original citation] - Published by The Royal Society of Chemistry (RSC) on behalf of the European Society for Photobiology, the European Photochemistry Association, and RSC.
    • For reproduction of material from all other RSC journals:
      [Original citation] - Published by The Royal Society of Chemistry.

    Information about reproducing material from RSC articles with different licences is available on our Permission Requests page.

Search articles by author

Spotlight

Advertisements